Table 3. Target volumes and timing of radiotherapy (RT) for initially diagnosed oligometastatic prostate cancer (n=76).

	N	%
Target volume
1. No case	27	36
2. No RT	0	0
3. Prostate only	4	5
4. Up to 1–2 metastases only	5	7
5. Up to 3 metastases only	3	4
6. Up to 4–5 metastases only	0	0
7. Prostate and up to 1–2 metastases	14	18
8. Prostate and up to 3 metastases	16	21
9. Prostate and up to 4–5 metastases	6	8
10. Case by case	1	1
RT timing
1. No case	27	36
2. Concurrent with ADT ≤1 month	10	13
3. Delay after neoadjuvant ADT 2–8 months	23	30
4. As soon as possible because patients are consulted for RT after ADT ≥6 months	11	14
5. Case by case	5	7

ADT, androgen deprivation therapy.